phosphorus has been researched along with fluoxetine in 7 studies
| Studies (phosphorus) | Trials (phosphorus) | Recent Studies (post-2010) (phosphorus) | Studies (fluoxetine) | Trials (fluoxetine) | Recent Studies (post-2010) (fluoxetine) |
|---|---|---|---|---|---|
| 48,074 | 1,126 | 17,139 | 10,100 | 1,663 | 3,263 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (28.57) | 18.2507 |
| 2000's | 1 (14.29) | 29.6817 |
| 2010's | 1 (14.29) | 24.3611 |
| 2020's | 3 (42.86) | 2.80 |
| Authors | Studies |
|---|---|
| Baker, GB; Coutts, RT; Goodnough, DB | 1 |
| Bessard, G; Fontanille, P; Jourdil, N; Villier, C | 1 |
| Ulrich, S | 1 |
| Fiedler, KK; Hellem, TL; Jeong, EK; Kondo, DG; Renshaw, PF; Shi, X; Sung, YH | 1 |
| Cheng, H; Hu, P; Jin, L; Pan, B; Qin, K; Wang, S; Wang, X; Wang, Y; Wu, L; Xin, H; Zhang, W | 1 |
| Bian, R; Sun, Y; Yuan, Q; Zhang, D; Zhang, J; Zhao, J | 1 |
| Delerue-Matos, C; Fernandes, DF; Figueiredo, SA; Freitas, OM; Silva, ADM | 1 |
1 trial(s) available for phosphorus and fluoxetine
| Article | Year |
|---|---|
Open-label adjunctive creatine for female adolescents with SSRI-resistant major depressive disorder: a 31-phosphorus magnetic resonance spectroscopy study.
Topics: Adolescent; Antidepressive Agents; Creatine; Depressive Disorder; Depressive Disorder, Major; Female; Fluoxetine; Follow-Up Studies; Humans; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Magnetics; Phosphocreatine; Phosphorus; Radionuclide Imaging; Selective Serotonin Reuptake Inhibitors; Treatment Outcome | 2011 |
6 other study(ies) available for phosphorus and fluoxetine
| Article | Year |
|---|---|
Simultaneous quantification of fluoxetine, norfluoxetine, and desipramine using gas chromatography with nitrogen-phosphorus detection.
Topics: Animals; Antidepressive Agents; Brain Chemistry; Chromatography, Gas; Desipramine; Drug Interactions; Fluoxetine; Liver; Male; Mass Spectrometry; Nitrogen; Phosphorus; Rats; Rats, Sprague-Dawley; Reference Standards; Tissue Distribution | 1995 |
Direct analysis of fluoxetine and norfluoxetine in plasma by gas chromatography with nitrogen-phosphorus detection.
Topics: Chromatography, Gas; Fluoxetine; Humans; Nitrogen; Phosphorus; Reproducibility of Results; Sensitivity and Specificity | 1997 |
Direct stereoselective assay of fluoxetine and norfluoxetine enantiomers in human plasma or serum by two-dimensional gas-liquid chromatography with nitrogen-phosphorus selective detection.
Topics: Antidepressive Agents, Second-Generation; Chromatography, Gas; Fluoxetine; Humans; Nitrogen; Phosphorus; Reproducibility of Results; Stereoisomerism | 2003 |
Fast-Acting Black-Phosphorus-Assisted Depression Therapy with Low Toxicity.
Topics: Animals; Behavior, Animal; Depression; Drug Carriers; Electrophysiological Phenomena; Fluoxetine; Kinetics; Mice; Phosphorus | 2020 |
Effect of fluoxetine on enhanced biological phosphorus removal using a sequencing batch reactor.
Topics: Biological Products; Bioreactors; Fluoxetine; Phosphorus; Polyhydroxyalkanoates | 2021 |
Fluoxetine and Nutrients Removal from Aqueous Solutions by Phycoremediation.
Topics: Adsorption; Chlorella vulgaris; Fluoxetine; Microalgae; Nitrogen; Nutrients; Phosphorus; Water; Water Pollutants, Chemical | 2022 |